Emergency Medicine Doctors in Davenport, FL Accepting Medicare

8 Emergency Medicine doctors found. Showing 1 - 8

Michael Anthony Boyer, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 40100 Highway 27, Davenport, FL 33837 Phone: 863-422-4971

Dr. Yaritza Arriaga Oneill, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 40100 Highway 27, Davenport, FL 33837 Phone: 863-422-4971

Dr. Robert Cruz Vergara, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 40100 Highway 27, Davenport, FL 33837 Phone: 863-422-4971    Fax: 863-419-2264

Michael Shamus Mchale, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 40100 Highway 27, Davenport, FL 33837 Phone: 863-422-4971

John Wescott Conboy, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 40100 Hwy 27, Davenport, FL 33837 Phone: 863-422-4971

Rafael Alberto Santiago Aponte, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 40100 Highway 27, Davenport, FL 33837 Phone: 863-422-4971    Fax: 863-419-2264

Mirand Reeb Sharma, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 40100 Highway 27, Davenport, FL 33837 Phone: 863-422-4971

Lynda-marie George, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 40100 Highway 27, Davenport, FL 33837 Phone: 863-422-4971

News Archive

Teva Pharmaceutical Industries receives FDA tentative approval for generic Femara Tablets

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Novartis' breast cancer treatment Femara® (letrozole) Tablets, 2.5 mg. Final approval of Teva's Letrozole Tablets is expected upon expiry of patent protection for the brand product in June 2011.

Vast majority of children with autism have difficulties that require therapeutic, educational support

Research in the past several years has shown that children can outgrow a diagnosis of autism spectrum disorder, once considered a lifelong condition.

Researchers discover genetic 'shut down' trigger in healthy immune cells

A fundamental genetic mechanism that shuts down an important gene in healthy immune system cells has been discovered that could one day lead to new therapies against infections, leukemia and other cancers.

RXi receives USPTO notices of allowance for certain siRNA sequence-specific patent applications

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Notices of Allowance were recently issued by the United States Patent Office (USPTO) on patent applications filed by Thermo Fisher Scientific Inc. and licensed to RXi Pharmaceuticals encompassing small interfering RNA (siRNA) sequences targeting superoxide dismutase (SOD1), Amyloid beta (A4) precursor protein (APP), interleukin-1 receptor-associated kinase 4 (IRAK4), hepatocyte growth factor receptor (MET protooncogene) and cyclin-dependent kinase (cdk) inhibitor p27 (also known as Kip1, CDKN1B).

New understanding of seizure behaviors and epilepsy

Two children have a seizure. One child never has another seizure. Twenty years later, the other child has a series of seizures and is diagnosed with epilepsy.

Read more Medical News

› Verified 2 days ago